Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

The FDA recently approved Guardant Health’s “Shield” blood test for colorectal cancer (CRC) screening in adults aged 45 and ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

Expanded eligibility criteria and new tests for national cancer screening programs are to be introduced on Wednesday next ...

The Health Promotion Administration (HPA) is to increase public funding for painless colonoscopy screenings for high-risk ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

One’s biological age, which measures the body’s physiological state, may help predict who is at risk for developing colon ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test, ColoAlert. The test leverages polymerase chain ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Improvements in cancer prevention and screening have averted more deaths than treatment advances over the past 45 years.

Colorectal cancer (CRC) is the third most common cancer globally, with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund. The US Preventive Services Task Force ...